Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression

Serial analysis of gene expression (SAGE) is a powerful tool for the discovery of novel tumor markers. The publicly available on-line SAGE libraries of normal and neoplastic tissues (http://www.ncbi.nlm.nih.gov/SAGE/) have recently been expanded; in addition, a more complete annotation of the human genome and better biocomputational techniques have substantially improved the assignment of differentially expressed SAGE “tags” to human genes. These improvements have provided us with an opportunity to re-evaluate global gene expression in pancreatic cancer using existing SAGE libraries. SAGE libraries generated from 6 pancreatic cancers were compared to SAGE libraries generated from 11 non-neoplastic tissues. Compared to normal tissue libraries, we identified 453 SAGE tags as differentially expressed in pancreatic cancer, including 395 that mapped to known genes and 58 “uncharacterized” tags. Of the 395 SAGE tags assigned to known genes, 223 were overexpressed in pancreatic cancer, and 172 were underexpressed. In order to map the 58 uncharacterized differentially expressed SAGE tags to genes, we used a newly developed resource called TAGmapper (http://tagmapper.ibioinformatics.org), to identify 16 additional differentially expressed genes. The differential expression of 7 genes, involved in multiple cellular processes such as signal transduction (MIC-1), differentiation (DMBT1 and Neugrin), immune response (CD74), inflammation (CXCL2), cell cycle (CEB1) and enzymatic activity (Kallikrein 6), was confirmed by either immunohistochemical labeling of tissue microarrays (Kallikrein 6, CD74 and DMBT1) or by RT-PCR (CEB1, Neugrin, MIC1, and CXCL2). Of note, Neugrin was one of the genes whose previously uncharacterized SAGE tag was correctly assigned using TAGmapper, validating the utility of this program. Novel differentially expressed genes in a cancer type can be identified by revisiting updated and expanded SAGE databases. TAGmapper should prove to be a powerful tool for the discovery of novel tumor markers through assignment of uncharacterized SAGE tags.

[1]  Troels Z. Kristiansen,et al.  Comprehensive proteomic analysis of human pancreatic juice. , 2004, Journal of proteome research.

[2]  K. Kinzler,et al.  Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers , 2004, Clinical Cancer Research.

[3]  M. Bittner,et al.  Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome , 2004, Oncogene.

[4]  R. Sue,et al.  CXCR2 Is Critical to Hyperoxia-Induced Lung Injury1 , 2004, The Journal of Immunology.

[5]  A. Poustka,et al.  Carcinogen inducibility in vivo and down‐regulation of DMBT1 during breast carcinogenesis , 2004, Genes, chromosomes & cancer.

[6]  J. Cameron,et al.  Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. , 2004, The American journal of pathology.

[7]  R. Hruban,et al.  Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  E. Diamandis,et al.  Immunohistochemical Localization of Human Kallikreins 6 and 10 in Pancreatic Islets , 2002, The Histochemical Journal.

[9]  G. Yousef,et al.  In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. , 2004, Anticancer research.

[10]  Christine A Iacobuzio-Donahue,et al.  Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. , 2003, Cancer research.

[11]  A. Poustka,et al.  Decrease of Deleted in Malignant Brain Tumour‐1 (DMBT‐1) expression is a crucial late event in intrahepatic cholangiocarcinoma , 2003, Histopathology.

[12]  D. Faigel,et al.  Novel Markers of Pancreatic Adenocarcinoma in Fine-Needle Aspiration: Mesothelin and Prostate Stem Cell Antigen Labeling Increases Accuracy in Cytologically Borderline Cases , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[13]  J. Cameron,et al.  Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray , 2003, Modern Pathology.

[14]  R. Ransohoff,et al.  Chemokine Upregulation Follows Cytokine Expression in Chronic Relapsing Experimental Autoimmune Encephalomyelitis , 2003, Scandinavian journal of immunology.

[15]  K. Kinzler,et al.  MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  S. Batra,et al.  Dysregulated expression of MIC-1/PDF in human prostate tumor cells. , 2003, Biochemical and biophysical research communications.

[17]  D. Katsaros,et al.  Parallel overexpression of seven kallikrein genes in ovarian cancer. , 2003, Cancer research.

[18]  Zhi-jun Tan,et al.  Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray. , 2003, World journal of gastroenterology.

[19]  W. Kang,et al.  DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration? , 2003, FEBS letters.

[20]  M. Brechbiel,et al.  A comparison of 4 radionuclides conjugated to antibodies for single-cell kill. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  M. Burdick,et al.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. , 2002, The Journal of clinical investigation.

[22]  M. Oka,et al.  Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. , 2002, Cancer research.

[23]  George M Yousef,et al.  Human tissue kallikreins: a family of new cancer biomarkers. , 2002, Clinical chemistry.

[24]  Angie Rizzino,et al.  Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. , 2002, Carcinogenesis.

[25]  Haiyong Han,et al.  Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. , 2002, Cancer research.

[26]  Kimberly Walter,et al.  Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. , 2002, The American journal of pathology.

[27]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[28]  Giovanni Parmigiani,et al.  Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. , 2002, Cancer research.

[29]  J. Cameron,et al.  Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[31]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[32]  S. Natsugoe,et al.  Invariant chain expression in gastric cancer. , 2001, Cancer letters.

[33]  J. Cameron,et al.  Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. , 2001, Cancer research.

[34]  F. Marshall,et al.  Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. , 2001, The American journal of pathology.

[35]  K. Kinzler,et al.  Secreted and cell surface genes expressed in benign and malignant colorectal tumors. , 2001, Cancer research.

[36]  D. Goldenberg,et al.  Single-cell cytotoxicity with radiolabeled antibodies. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  G. Sobue,et al.  Two novel genes, human neugrin and mouse m-neugrin, are upregulated with neuronal differentiation in neuroblastoma cells. , 2000, Biochemical and biophysical research communications.

[38]  G. Yousef,et al.  Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. , 2000, Clinical biochemistry.

[39]  G. Freeman,et al.  Expression of MHC Class II-Associated Invariant Chain (Ii;CD74) in Thymic Epithelial Neoplasms , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[40]  A. Poustka,et al.  DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. , 2000, Cancer research.

[41]  A. Yoshimura,et al.  A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins. , 1999, Biochemical and biophysical research communications.

[42]  Minzhen Xu,et al.  Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells , 1999, Cancer Immunology, Immunotherapy.

[43]  D. Warburton,et al.  Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas. , 1999, American journal of physiology. Renal physiology.

[44]  Zhong Jiang,et al.  Invariant chain expression in colon neoplasms , 1999, Virchows Archiv.

[45]  J. Minna,et al.  Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. , 1999, Cancer research.

[46]  K. Mafune,et al.  Lack of DMBT1 expression in oesophageal, gastric and colon cancers , 1999, British Journal of Cancer.

[47]  M. Tsao,et al.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. , 1998, The American journal of pathology.

[48]  J. Cameron,et al.  Prognostic factors in ductal pancreatic cancer , 1998, Langenbeck's Archives of Surgery.

[49]  Jan Mollenhauer,et al.  DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.

[50]  M. Tsao,et al.  Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. , 1996, The American journal of pathology.

[51]  S. Ceman,et al.  The function of invariant chain in class II-restricted antigen presentation. , 1995, Seminars in immunology.

[52]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.